Disposition of 365551 shares by Gold Daniel Allen of Roivant Sciences at 11.7653 subject to Rule 16b-3

ROIV Stock  USD 11.37  0.24  2.16%   
Slightly above 57% of Roivant Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Roivant Sciences suggests that many traders are alarmed. Roivant Sciences' investing sentiment can be driven by a variety of factors including economic data, Roivant Sciences' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Roivant Sciences Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at finance.yahoo.com
Yahoo News
  

Roivant Sciences Current Investor Sentiment

Panic Vs Confidence

43

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Roivant Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Roivant Sciences.

Roivant Sciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Roivant Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Roivant Sciences Fundamental Analysis

We analyze Roivant Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Roivant Sciences is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Roivant Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Roivant Sciences stock to make a market-neutral strategy. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics with similar companies.

Peers

Roivant Sciences Related Equities

RVMDRevolution Medicines   5.21   
0%
100.0%
VRDNViridian Therapeutics   3.35   
0%
64.0%
APLSApellis Pharmaceuticals   3.12   
0%
59.0%
INZYInozyme Pharma   2.82   
0%
54.0%
AKROAkero Therapeutics   2.50   
0%
47.0%
LYRALyra Therapeutics   1.67   
0%
32.0%
KRYSKrystal Biotech   0.15   
2.0%
0%
ASNDAscendis Pharma   0.20   
3.0%
0%
SNDXSyndax Pharmaceuticals   0.21   
4.0%
0%
BPMCBlueprint Medicines   0.24   
4.0%
0%
PLRXPliant Therapeutics   0.74   
14.0%
0%
DAWNDay One   1.15   
22.0%
0%
CGEMCullinan Oncology   2.40   
46.0%
0%
PHATPhathom Pharmaceuticals   3.21   
61.0%
0%

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.